You are here

Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients.

Cho J, Choi E, Kim I, Im Y, Park Y, Lee S, Lee J, Yang J, Nam S.

Ann Oncol. 2014 Feb;25(2):346-51.

Editors' comments: Dr. Ricardo Caponero

Alopecia is a common side effect of a large number of chemotherapy regimens. No medications are useful to palliate this symptom and capillary prosthesis remains the only solution possible. Considered inevitable, this symptom is frequently set aside clinical decisions but its impact on quality of life is not measurable.
Now, Cho and cols. developed and validated a psychometric scale for assessing the distress that breast cancer patients experience from alopecia caused by their cancer treatment.